Anti-CD19 Reference Antibody (tafasitamab)
产品性质
应用案例
Purity
Anti-CD19 Reference Antibody (tafasitamab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
SEC-HPLC
The purity of Anti-CD19 Reference Antibody (tafasitamab) is 98.59%, determined by SEC-HPLC.
ELISA
Immobilized human CD19 (20 291) Protein, His Tag at 2 μg/mL can bind Anti-CD19 Reference Antibody (tafasitamab), EC50=0.0904 μg/mL.
Human CD19 HEK293 cells were stained with Anti-CD19 Reference Antibody (tafasitamab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.085 μg/mL.
存储条件
-25~-15℃保存，有效期1年。
COA
相关产品
联系我们
